Bank Of America Corp Aurinia Pharmaceuticals Inc. Transaction History

Bank Of America Corp

  • $1.43 Trillion
  • Q3 2025

A detailed history of Bank Of America Corp transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Bank Of America Corp holds 521,363 shares of AUPH stock, worth $8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
521,363
Previous 470,791 10.74%
Holding current value
$8 Million
Previous $3.99 Million 44.49%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$7.47 - $13.14 $377,772 - $664,516
50,572 Added 10.74%
521,363 $5.76 Million
Q2 2025

Aug 14, 2025
BUY
$7.2 - $8.64 $530,064 - $636,076
73,620 Added 18.54%
470,791 $3.99 Million
Q1 2025

May 15, 2025
BUY
$7.55 - $8.77 $2.52 Million - $2.92 Million
333,196 Added 520.82%
397,171 $3.19 Million
Q4 2024

Feb 14, 2025
SELL
$6.75 - $10.44 $747,326 - $1.16 Million
-110,715 Reduced 63.38%
63,975 $574,000
Q3 2024

Nov 14, 2024
BUY
$5.32 - $7.33 $118,721 - $163,576
22,316 Added 14.65%
174,690 $1.28 Million
Q2 2024

Aug 14, 2024
BUY
$4.81 - $5.78 $173,010 - $207,900
35,969 Added 30.9%
152,374 $870,000
Q1 2024

May 15, 2024
BUY
$4.93 - $9.31 $231,665 - $437,486
46,991 Added 67.7%
116,405 $583,000
Q4 2023

Feb 14, 2024
BUY
$7.13 - $9.49 $43,236 - $57,547
6,064 Added 9.57%
69,414 $624,000
Q2 2023

Aug 14, 2023
SELL
$8.96 - $11.69 $357,996 - $467,073
-39,955 Reduced 38.68%
63,350 $613,000
Q1 2023

May 12, 2023
SELL
$5.94 - $11.27 $1.81 Million - $3.44 Million
-305,421 Reduced 74.73%
103,305 $1.13 Million
Q4 2022

Feb 10, 2023
BUY
$4.11 - $8.14 $614,481 - $1.22 Million
149,509 Added 57.68%
408,726 $1.77 Million
Q3 2022

Nov 14, 2022
BUY
$6.66 - $12.39 $879,672 - $1.64 Million
132,083 Added 103.89%
259,217 $1.95 Million
Q2 2022

Aug 12, 2022
BUY
$8.95 - $12.8 $645,849 - $923,673
72,162 Added 131.27%
127,134 $1.28 Million
Q1 2022

May 16, 2022
SELL
$10.05 - $22.48 $72,661 - $162,530
-7,230 Reduced 11.62%
54,972 $680,000
Q4 2021

Feb 08, 2022
BUY
$17.78 - $33.08 $324,609 - $603,941
18,257 Added 41.55%
62,202 $1.42 Million
Q3 2021

Nov 15, 2021
SELL
$10.93 - $23.55 $148,833 - $320,680
-13,617 Reduced 23.66%
43,945 $973,000
Q2 2021

Sep 13, 2021
BUY
$10.0 - $14.52 $575,620 - $835,800
57,562 New
57,562 $746,000

Others Institutions Holding AUPH

# of Institutions
268
Shares Held
69.3M
Call Options Held
984K
Put Options Held
574K
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $2.18B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email